Sanara Medtech, Inc. (SMTI)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$34.73+0.03%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · SMTI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 109.8 | 103.1 | 86.7 | 65.0 | 45.8 | 24.1 | 15.6 | — | 5.8 | 6.3 | 5.5 | 3.4 | 2.6 | 1.7 | 1.2 | 2.2 |
| Total Revenues | — | — | — | — | — | — | 15.6 | — | 5.8 | 6.3 | 5.5 | 3.4 | 2.6 | 1.7 | 1.2 | 2.2 |
| Cost of Revenues | 7.7 | 7.5 | 8.1 | 7.9 | 6.4 | 2.3 | 1.6 | — | 0.5 | — | — | — | — | — | — | — |
| Gross Profit | 102.2 | 95.6 | 78.5 | 57.1 | 39.5 | 21.8 | 14.0 | — | 5.3 | 5.5 | 4.6 | 2.5 | 1.8 | 0.9 | 0.4 | 1.4 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 84.4 | 78.7 | 76.6 | 57.0 | 46.0 | 28.1 | — | — | — | — | — | — | — | — | — | 2.7 |
| R&D Expenses | 5.0 | 5.1 | 5.7 | 4.1 | 3.4 | 0.6 | 0.0 | — | — | — | — | — | — | — | — | — |
| Operating Income | 8.4 | 7.3 | (6.7) | (4.2) | (12.5) | (7.4) | (5.0) | — | (0.5) | 0.1 | (0.3) | — | — | — | (1.8) | (5.0) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | 7.3 | 6.8 | 3.1 | 0.5 | 0.3 | 0.0 | 0.0 | — | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 1.7 | 0.3 | (0.3) |
| Interest & Investment Income | — | — | — | — | — | — | — | — | (0.0) | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.3 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 1.6 | 0.1 | (0.5) |
| Asset Writedown | — | 28.3 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (0.4) | — | (4.4) | (13.9) | (8.0) | — | — | — | — | — | — | — | — | (1.8) | (12.7) |
| Income Tax Expense | — | — | (0.0) | — | (5.8) | — | 0.0 | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — |
| Net Income | ||||||||||||||||
| Minority Interest | — | (0.0) | (0.2) | (0.1) | (0.2) | (0.1) | (0.1) | — | — | — | — | — | — | — | — | — |
| Net Income | 43.1 | (37.6) | (9.7) | 4.3 | (7.9) | (7.9) | (4.4) | — | (0.6) | 0.3 | (0.4) | (1.3) | (2.3) | (4.1) | (1.8) | (12.7) |
| Per Share | ||||||||||||||||
| Basic EPS | 4.98 | (4.36) | (1.14) | (0.52) | (1.00) | (1.08) | (0.76) | — | 0.00 | 0.00 | — | — | — | — | — | — |
| Diluted EPS | 4.98 | (4.36) | (1.14) | (0.52) | (1.00) | — | (0.76) | — | 0.00 | 0.00 | — | — | — | — | — | — |
| Revenue per Share | 12.68 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 8.7 | 8.6 | 8.5 | 8.3 | 7.9 | 7.3 | 5.7 | — | 217.2 | 111.4 | 108.6 | 106.7 | 87.9 | 77.7 | — | 54.7 |
| Diluted Weighted Avg Shares | 8.7 | 8.6 | 8.5 | 8.3 | 7.9 | 7.3 | 5.7 | — | 217.2 | 208.6 | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | 10.0 | (1.8) | (0.5) | (10.1) | (6.8) | (4.7) | — | (0.4) | 0.2 | (0.2) | — | — | — | (1.8) | (4.5) |
| EBIT | 8.4 | 7.3 | (6.7) | (4.2) | (12.5) | (7.4) | (5.0) | — | (0.5) | 0.1 | (0.3) | — | — | — | (1.8) | (5.0) |
| Effective Tax Rate | — | — | — | — | 41.9% | — | — | — | — | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.